These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3035791)

  • 1. Defective interfering particles of human parainfluenza virus 3.
    Murphy DG; Dimock K; Kang CY
    Virology; 1987 Jun; 158(2):439-43. PubMed ID: 3035791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral RNA and protein synthesis in two LLC-MK2 cell lines persistently infected with human parainfluenza virus 3.
    Murphy DG; Dimock K; Kang CY
    Virus Res; 1990 Apr; 16(1):1-16. PubMed ID: 1693460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective interfering particles of human parainfluenza virus type 3 are associated with persistent infection in cell culture.
    Moscona A
    Virology; 1991 Aug; 183(2):821-4. PubMed ID: 1649512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of defective-interfering particles by rubella virus in Vero cells.
    Frey TK; Hemphill ML
    Virology; 1988 May; 164(1):22-9. PubMed ID: 3363865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human parainfluenza virus type 3 persistent infection in cell culture.
    Moscona A; Galinski MS
    J Virol; 1990 Jul; 64(7):3212-8. PubMed ID: 2161938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Toscana virus-defective interfering particles generated in vivo.
    Marchi A; Nicoletti L; Accardi L; Di Bonito P; Giorgi C
    Virology; 1998 Jun; 246(1):125-33. PubMed ID: 9657000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Bunyamwera virus defective interfering particles.
    Patel AH; Elliott RM
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():389-96. PubMed ID: 1538195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent infection with human parainfluenza virus 3 in CV-1 cells: analysis of the role of defective interfering particles.
    Moscona A; Peluso RW
    Virology; 1993 May; 194(1):399-402. PubMed ID: 8386885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Sendai virus defective-interfering genomes with internal deletions.
    Hsu CH; Re GG; Gupta KC; Portner A; Kingsbury DW
    Virology; 1985 Oct; 146(1):38-49. PubMed ID: 2994295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles.
    DePolo NJ; Giachetti C; Holland JJ
    J Virol; 1987 Feb; 61(2):454-64. PubMed ID: 3027375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.
    Schmidt AC; McAuliffe JM; Huang A; Surman SR; Bailly JE; Elkins WR; Collins PL; Murphy BR; Skiadopoulos MH
    J Virol; 2000 Oct; 74(19):8922-9. PubMed ID: 10982335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins.
    Skiadopoulos MH; Surman SR; Riggs JM; Orvell C; Collins PL; Murphy BR
    Virology; 2002 May; 297(1):136-52. PubMed ID: 12083844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses.
    Storey DG; Côté MJ; Dimock K; Kang CY
    Intervirology; 1987; 27(2):69-80. PubMed ID: 2822598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal.
    Makino S; Yokomori K; Lai MM
    J Virol; 1990 Dec; 64(12):6045-53. PubMed ID: 2243386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5.
    Murphy SK; Parks GD
    Virology; 1997 May; 232(1):145-57. PubMed ID: 9185598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective interfering particles of VSVNJ (Ogden), generated by heat treatment, contain multiple internal genomic deletions.
    Rud EW; Banerjee AK; Kang CY
    Virology; 1986 Nov; 155(1):61-76. PubMed ID: 3022478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.
    Spriggs MK; Collins PL
    J Virol; 1986 Sep; 59(3):646-54. PubMed ID: 3016327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal.
    Bos EC; Dobbe JC; Luytjes W; Spaan WJ
    J Virol; 1997 Jul; 71(7):5684-7. PubMed ID: 9188649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step.
    Odagiri T; Tashiro M
    J Virol; 1997 Mar; 71(3):2138-45. PubMed ID: 9032347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.